title: High incidence of osteonecrosis of femoral head in patients receiving more than 2 g of intravenous methylprednisolone after renal transplantation.
authors.affiliation: Department of Orthopaedic Surgery, Chiba University, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Saisu
authors.forename: K
authors.initials: K
authors.lastname: Sakamoto
authors.forename: K
authors.initials: K
authors.lastname: Yamada
authors.forename: H
authors.initials: H
authors.lastname: Kashiwabara
authors.forename: T
authors.initials: T
authors.lastname: Yokoyama
authors.forename: S
authors.initials: S
authors.lastname: Iida
authors.forename: Y
authors.initials: Y
authors.lastname: Harada
authors.forename: S
authors.initials: S
authors.lastname: Ikenoue
authors.forename: M
authors.initials: M
authors.lastname: Sakamoto
authors.forename: H
authors.initials: H
authors.lastname: Moriya
mesh_terms: D000328:Adult; D004305:Dose-Response Relationship, Drug; D005260:Female; D005269:Femur; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015994:Incidence; D007275:Injections, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D010020:Osteonecrosis / Q000139:chemically induced / Q000453:epidemiology*
chemical_list: D007166:Immunosuppressive Agents; D008775:Methylprednisolone